Experienced in Cholangiocarcinoma (Bile Duct Cancer)

Stephen J. Clarke

Chris O'Brien Lifehouse
Sydney, NSW, AU 
Experienced in Cholangiocarcinoma (Bile Duct Cancer)
Chris O'Brien Lifehouse
Sydney, NSW, AU 
OverviewLocationsClinical Research

Overview

Stephen Clarke practices in Sydney, Australia. Mr. Clarke is rated as an Experienced expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Mesothelioma, Colorectal Cancer, Lung Cancer, Tissue Biopsy, and Pancreaticoduodenectomy.

His clinical research consists of co-authoring 270 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Chris O'Brien Lifehouse
Sydney, NSW 2050, Australia
Other Locations
St Leonards And Frenchs Forest, St Leonards, NSW, Australia
46/40 W Thebarton Rd, Thebarton, SA 5031, Australia
Hospital Road, Concord, NSW 2139, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase Ib/II Study of Intra-Arterial Liver Isolation Chemotherapy in Patients With Hepatic Metastases From Colorectal Cancer
Phase Ib/II Study of Intra-Arterial Liver Isolation Chemotherapy in Patients With Hepatic Metastases From Colorectal Cancer
Enrollment Status: Terminated
Publish Date: September 18, 2025
Intervention Type: Combination product
Study Phase: Phase 1/Phase 2
Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET
Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET
Enrollment Status: Completed
Publish Date: October 28, 2022
Intervention Type: Other
Study Phase: Not Applicable
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug, Other
Study Phase: Phase 3
MesomiR 1: A Phase I Study of Intravenously Administered Epidermal Growth Factor Receptor -Targeted, EnGeneIC Delivery Vehicle (EDV)-Packaged, miR-16 Mimic (TargomiRs) for Patients With Malignant Pleural Mesothelioma (MPM) and Advanced Non-Small Cell Lung Cancer (NSCLC) Failing on Std Therapy
MesomiR 1: A Phase I Study of Intravenously Administered Epidermal Growth Factor Receptor -Targeted, EnGeneIC Delivery Vehicle (EDV)-Packaged, miR-16 Mimic (TargomiRs) for Patients With Malignant Pleural Mesothelioma (MPM) and Advanced Non-Small Cell Lung Cancer (NSCLC) Failing on Std Therapy
Enrollment Status: Completed
Publish Date: April 07, 2017
Intervention Type: Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

270 Total Publications

[18F]FMISO PET in metastatic neuroendocrine tumours: a pilot study.
[18F]FMISO PET in metastatic neuroendocrine tumours: a pilot study.
Journal: Asia Oceania journal of nuclear medicine & biology
Published: June 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Clarke's expertise for a condition
ConditionClose
View All 30 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile